Skip to Content

Better Ways to Communicate Hospital Data to Physicians

From Harvard Business Review, October 31, 2018 By Scott Falk, MD, Director of Performance Improvement, Quality and Safety; and Associate Professor of Anesthesiology and Critical Care, Penn Medicine (University of Pennsylvania Health System), Physician Advisor, Lumere; John Cherf, MD, MPH, MBA, Chief of Orthopedic Surgery, Advocate Illinois Masonic Medical Center (Advocate Aurora… read more

Providing valuable care to joint replacement patients

by John Cherf, MD, MPH, MBA, Chief Medical Officer, Lumere, and Simon Kerr, Ortho-Spine Category Advisor and Research Specialist, Lumere, MedTech Outlook, September 2018 These are exciting but uncertain times for the field of orthopedics, particularly major joint replacements. As rapid changes in policy, sites of care and technologies (both… read more

A digest for doctors overwhelmed by studies

By one count, more than 2 million scientific studies are published each year. This is where Lumere comes in. by H. Lee Murphy, Crain’s Chicago Business, August 22, 2018 By one count, more than 2 million scientific studies are published each year in some 28,000 journals. It’s the rare physician or hospital these days that isn’t… read more

The best thing Lumere co-founder Eric Meizlish recently read? Jeff Bezos’ letter to Amazon shareholders

Becker’s Hospital Review, July 2, 2018 In this special Speaker Series, Becker’s Healthcare caught up with Eric Meizlish, co-founder, president and chief strategy officer of Lumere, formerly known as Procured Health. Mr. Meizlish will speak during the Becker’s Hospital Review 4th Annual Health IT + Revenue Cycle Conference on “Chicago Companies Leading… read more

Robotics, MIS, complex cases, oh my — Dr. Egon Doppenberg discusses the evolution of spine surgery

by Mackenzie Garrity, Becker’s Spine Review, March 28, 2018 Egon Doppenberg, MD, is a neurosurgeon and physician advisor with Lumere. In a recent interview with Becker’s Spine Review, Dr. Doppenberg talked about the evolution of spine surgery and new advancements in minimally invasive surgery. Question: How has minimally invasive spine surgery… read more

Keep Supply Lines Fluid: ASCs, Outpatient Facilities Shouldn’t Have to Fish for Hospital Contracts

by Rick Dana Barlow, Healthcare Purchasing News, March 23, 2018 Much of the concentration and focus on supply chain operations in non-acute care settings centers on class-of-trade complaints, ranging from contract pricing to distribution costs to effective but efficient inventory management. Many participants in supply chain operations recognize and understand… read more

Becoming Good Stewards of Orthopaedic Technology by Lumere CMO John Cherf, MD, MPH, MBA

Although I attended my first AAOS Annual Meeting more than 20 years ago, I still remember the excitement of exploring the “trade floor” and its abundance of new technology for the first time. However, my ability to access the new products at the largest orthopaedic meeting in the world was… read more

Biosimilars: Disruption or Disappointment?

In a recent blog post, Allison Wu asks whether biosimilars are a disruption or a disappointment? Branded as “Inflectra”, this form of infliximab is developed by Celltrion and will be co-marketed by Pfizer. Despite steadily rising interest in biosimilars over the past 5 years, Inflectra is only the second true biosimilar drug… read more

Is Over-diagnosis, Over-treatment, or Over-prescribing Ailing You?

In a recent blog post by Gina Thomas, RN, MBA, Chief Development Officer of Procured Health asks is over-diagnosis, over-treatment, or over-prescribing ailing you? With healthcare costs 18% of GDP and wastes in healthcare costs such as overtreatment escalating to heights over $130 billion, our society of convenience and demand to ‘fix me now’ may be causing… read more

An Inside Look at Cardiovascular Technology

A recently published whitepaper on Rapid Innovation in Cardiovascular Technology: explores the clinical evidence in three cardiovascular devices Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of innovative technology and the leading… read more